Retinal cholesterol metabolism is perturbated in response to experimental glaucoma in the rat

PLoS One. 2022 Mar 11;17(3):e0264787. doi: 10.1371/journal.pone.0264787. eCollection 2022.

Abstract

Alterations of cholesterol metabolism have been described for many neurodegenerative pathologies, such as Alzheimer's disease in the brain and age-related macular degeneration in the retina. Recent evidence suggests that glaucoma, which is characterized by the progressive death of retinal ganglion cells, could also be associated with disruption of cholesterol homeostasis. In the present study we characterized cholesterol metabolism in a rat model of laser-induced intraocular hypertension, the main risk factor for glaucoma. Sterol levels were measured using gas-chromatography and cholesterol-related gene expression using quantitative RT-PCR at various time-points. As early as 18 hours after the laser procedure, genes implicated in cholesterol biosynthesis and uptake were upregulated (+49% and +100% for HMG-CoA reductase and LDLR genes respectively, vs. naive eyes) while genes involved in efflux were downregulated (-26% and -37% for ApoE and CYP27A1 genes, respectively). Cholesterol and precursor levels were consecutively elevated 3 days post-laser (+14%, +40% and +194% for cholesterol, desmosterol and lathosterol, respectively). Interestingly, counter-regulatory mechanisms were transcriptionally activated following these initial dysregulations, which were associated with the restoration of retinal cholesterol homeostasis, favorable to ganglion cell viability, one month after the laser-induced ocular hypertension. In conclusion, we report here for the first time that ocular hypertension is associated with transient major dynamic changes in retinal cholesterol metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cholesterol / metabolism
  • Disease Models, Animal
  • Glaucoma* / metabolism
  • Ocular Hypertension* / metabolism
  • Rats
  • Retina / pathology
  • Retinal Ganglion Cells / pathology

Substances

  • Cholesterol

Grants and funding

This work was supported by grants from the Institut National de la Recherche Agronomique; the Conseil Régional Bourgogne, Franche-Comté (PARI grant); the FEDER (European Funding for Regional Economical Development); the Fondation de France/Fondation de l’œil; the Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation; the Université de Bourgogne Franche-Comté; and the Nouvelle Société Française d’Athérosclérose. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.